255 results on '"Yusuke, Takeda"'
Search Results
2. A Higher Neutrophil Count Is Associated with Favorable Achievement of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia Who Received Second Generation Tyrosine Kinase Inhibitor as Frontline Treatment
- Author
-
Hiroshi Ureshino, Yusuke Takeda, Kazuharu Kamachi, Takaaki Ono, Noriyoshi Iriyama, Eiichi Ohtsuka, Emiko Sakaida, and Shinya Kimura
- Subjects
chronic myeloid leukemia ,treatment-free remission ,tyrosine kinase inhibitors ,neutrophil ,cancer immunology ,Medicine (General) ,R5-920 - Abstract
Background: ABL1 tyrosine kinase inhibitor discontinuation securely became among the therapeutic goal for chronic myeloid leukemia chronic phase patients (CML-CP). To establish successful prognostic factors for treatment-free remission (TFR), it is necessary to diagnose the patients with high-risk molecular relapse, however, a biomarker for the achievement of TFR has not been completely elucidated. Recent investigations have determined that neutrophils function crucially in cancer immunology. Patients and Methods: The research was a multicenter retrospective observational study to examine the correlation between TFR and neutrophil counts before TKI discontinuation. The investigation included patients having Philadelphia chromosome-positive CML-CP who attempted the discontinuation of TKIs after a durable deep molecular response between January 2012 and July 2021 at four institutions in Japan. Results: 118 CML-CP patients in total discontinued TKIs and an estimated 36-month TFR rate was 65.1%. 52 patients received second-generation TKIs as frontline. Higher neutrophil count (>3210/μL) at TKIs discontinuation was determined as an independent prognostic variable for TFR in patients who received second-generation TKIs as frontline [(HR, 0.235 (95%, confidence interval (CI) 0.078–0.711); p = 0.010]. Conclusions: The neutrophil-mediated immunomodulation can be a significant component for the effective achievement of TFR in CML supported by our clinical observation.
- Published
- 2024
- Full Text
- View/download PDF
3. Evaluation of the extracranial 'multifocal arcuate sign,' a novel MRI finding for the diagnosis of giant cell arteritis, on STIR and contrast-enhanced T1-weighted images
- Author
-
Toshitada Hiraka, Yasuhiro Sugai, Yoshihiro Konno, Yuuki Toyoguchi, Yoshie Obata, Shin Ohara, Akiko Shibata, Yusuke Takeda, Koichi Nishitsuka, Kazunobu Ichikawa, Masafumi Watanabe, Yukihiko Sonoda, and Masafumi Kanoto
- Subjects
Giant cell arteritis ,MRI ,STIR ,Medical technology ,R855-855.5 - Abstract
Abstract Background While early diagnosis of giant cell arteritis (GCA) based on clinical criteria and contrast-enhanced MRI findings can lead to early treatment and prevention of blindness and cerebrovascular accidents, previously reported diagnostic methods which utilize contrast-enhanced whole head images are cumbersome. Diagnostic delay is common as patients may not be aware of initial symptoms and their significance. To improve current diagnostic capabilities, new MRI-based diagnostic criteria need to be established. This study aimed to evaluate the “multifocal arcuate sign” on short tau inversion recovery (STIR) and contrast-enhanced T1-weighted (CE-T1W) images as a novel extracranial finding for the diagnosis of GCA. Methods A total of 17 consecutive patients (including five with GCA) who underwent CE-T1W and whole-brain axial STIR imaging simultaneously between June 2010 and April 2020 were enrolled. We retrospectively reviewed their MR images. The “multifocal arcuate sign” was defined as “multiple distant arcuate areas with high signal intensity in extracranial soft tissues such as subcutaneous fat, muscles, and tendons.” Extracranial abnormal high-signal-intensity areas were classified as “None,” when no lesions were detected; “Monofocal,” when lesions were detected only in one place; and “Multifocal,” when lesions were detected in multiple places. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of “Multifocal” areas were calculated using cross tabulation. Fisher’s exact test was used to compare “Multifocal” areas in five patients with GCA and those with other diseases. In addition, mean Cohen’s kappa and Fleiss’ kappa statistics were used to compare inter-reader agreement. Results The sensitivity, specificity, PPV, and NPV of the “multifocal arcuate sign” in patients with GCA were 60%, 92–100%, 75–100%, and 85–86%, respectively. Significantly more patients with GCA had “Multifocal” areas compared to those with other diseases (Fisher’s exact test, p = 0.008–0.027). Mean Cohen’s kappa and Fleiss’ kappa for inter-reader agreement with respect to the five GCA patients were 0.52 and 0.49, respectively, for both STIR and CE-T1W sequences. Conclusions The new radiologic finding of “multifocal arcuate sign” on STIR and CE-T1W images may be used as a radiologic criterion for the diagnosis of GCA, which can make plain MRI a promising diagnostic modality.
- Published
- 2024
- Full Text
- View/download PDF
4. Detection of clonal plasma cells in POEMS syndrome using multiparameter flow cytometry
- Author
-
Arata Ishii, Shokichi Tsukamoto, Naoya Mimura, Yurie Miyamoto-Nagai, Yusuke Isshiki, Shinichiro Matsui, Sanshiro Nakao, Asuka Shibamiya, Yutaro Hino, Kensuke Kayamori, Nagisa Oshima-Hasegawa, Tomoya Muto, Yusuke Takeda, Tomoki Suichi, Sonoko Misawa, Chikako Ohwada, Koutaro Yokote, Satoshi Kuwabara, Chiaki Nakaseko, Hiroyuki Takamatsu, and Emiko Sakaida
- Subjects
POEMS syndrome ,Multiparameter flow cytometry ,EuroFlow ,Immunophenotype ,Medicine ,Science - Abstract
Abstract POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal protein [M-protein], and skin changes) is a rare systemic disorder characterized by various symptoms caused by underlying plasma cell (PC) dyscrasia. Detection of monoclonal PCs is mandatory for the diagnosis of POEMS syndrome; however, the usefulness of EuroFlow-based next-generation flow cytometry (EuroFlow-NGF) in POEMS syndrome for detecting monoclonal PCs in bone marrow (BM) and the gating strategy suitable for flow cytometry study of POEMS syndrome remain unknown. We employed EuroFlow-NGF-based single-tube eight-color multiparameter flow cytometry (MM-flow) and established a new gating strategy (POEMS-flow) to detect the monoclonal PCs in POEMS syndrome, gating CD38 broadly from dim to bright and CD45 narrowly from negative to dim compared to MM-flow. MM-flow detected monoclonal PCs in 9/25 (36.0%) cases, including 2/2 immunofixation electrophoresis (IFE)-negative cases (100%). However, POEMS-flow detected monoclonal PCs in 18/25 cases (72.0%), including 2/2 IFE-negative cases (100%). POEMS-flow detected monoclonal PCs with immunophenotypes of CD19− in 17/18 (94.4%). In six cases where post-treatment samples were available, the size of the clones was significantly reduced after the treatment (P = 0.031). POEMS-flow can enhance the identification rate of monoclonal PCs in POEMS syndrome and become a valuable tool for the diagnosis of POEMS syndrome.
- Published
- 2024
- Full Text
- View/download PDF
5. Prognostic factors for the development of lower respiratory tract infection after influenza virus infection in allogeneic hematopoietic stem cell transplantation recipients: A Kanto Study Group for Cell Therapy multicenter analysis
- Author
-
Kaito Harada, Makoto Onizuka, Takehiko Mori, Hiroaki Shimizu, Sachiko Seo, Nobuyuki Aotsuka, Yusuke Takeda, Noritaka Sekiya, Machiko Kusuda, Shinichiro Fujiwara, Sawako Shiraiwa, Katsuhiro Shono, Naoki Shingai, Heiwa Kanamori, Mamiko Momoki, Satoru Takada, Junichi Mukae, Shinichi Masuda, Kinuko Mitani, Emiko Sakaida, Tatsuki Tomikawa, Satoshi Takahashi, Kensuke Usuki, and Yoshinobu Kanda
- Subjects
Influenza virus ,Secondary pneumonia ,Hematopoietic stem cell transplantation ,Infectious and parasitic diseases ,RC109-216 - Abstract
Objectives: Influenza virus infection (IVI) occasionally causes lower respiratory tract infection (LRTI) in allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients. Although the progression to LRTI entails a high mortality, the role of early antiviral therapy for its prevention has not been fully elucidated. Methods: This was a multicenter retrospective study using an additional questionnaire. Allo-HSCT recipients who developed IVI between 2012 and 2020 were included. Results: A total of 278 cases of IVI after allo-HSCT were identified from 15 institutions. The median patient age was 49 years, and the median time from allo-HSCT to IVI was 918 days. Neuraminidase inhibitors were administered within 48 hours of symptom onset (early neuraminidase inhibitor [NAI]) in 199 (76.9%) patients. Subsequently, 36 (12.3%) patients developed LRTI. On the multivariate analysis, age ≥50 years (hazard ratio [HR], 2.16; 95% confidence interval [CI], 1.02-4.58) and moderate to severe chronic graft-versus-host disease (HR, 2.28; 95% CI, 1.14-4.58) were significantly associated with progression to LRTI, whereas early NAI suppressed the progression (HR, 0.17; 95% CI, 0.06-0.46). The IVI-related mortality rate was 2.2%. Conclusion: To reduce the risk of LRTI development after IVI, early NAI therapy should be considered in allo-HSCT recipients, especially with older patients and those with chronic graft-versus-host disease.
- Published
- 2023
- Full Text
- View/download PDF
6. Sensor array design of optically pumped magnetometers for accurately estimating source currents
- Author
-
Yusuke Takeda, Tomohiro Gomi, Ryu Umebayashi, Sadamu Tomita, Keita Suzuki, Nobuo Hiroe, Jiro Saikawa, Tatsuya Munaka, and Okito Yamashita
- Subjects
Optically pumped magnetometer (OPM) ,Magnetoencephalography (MEG) ,Sensor array ,Source imaging ,Resolution matrix ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
An optically pumped magnetometer (OPM) is a new generation of magnetoencephalography (MEG) devices that is small, light, and works at room temperature. Due to these characteristics, OPMs enable flexible and wearable MEG systems. On the other hand, if we have a limited number of OPM sensors, we need to carefully design their sensor arrays depending on our purposes and regions of interests (ROIs). In this study, we propose a method that designs OPM sensor arrays for accurately estimating the cortical currents at the ROIs. Based on the resolution matrix of minimum norm estimate (MNE), our method sequentially determines the position of each sensor to optimize its inverse filter pointing to the ROIs and suppressing the signal leakage from the other areas. We call this method the Sensor array Optimization based on Resolution Matrix (SORM). We conducted simple and realistic simulation tests to evaluate its characteristics and efficacy for real OPM-MEG data. SORM designed the sensor arrays so that their leadfield matrices had high effective ranks as well as high sensitivities to ROIs. Although SORM is based on MNE, the sensor arrays designed by SORM were effective not only when we estimated the cortical currents by MNE but also when we did so by other methods. With real OPM-MEG data we confirmed its validity for real data. These analyses suggest that SORM is especially useful when we want to accurately estimate ROIs’ activities with a limited number of OPM sensors, such as brain-machine interfaces and diagnosing brain diseases.
- Published
- 2023
- Full Text
- View/download PDF
7. ROCK2-induced metabolic rewiring in diabetic podocytopathy
- Author
-
Keiichiro Matoba, Yusuke Takeda, Yosuke Nagai, Kensuke Sekiguchi, Rikako Ukichi, Hiroshi Takahashi, Daisuke Aizawa, Masahiro Ikegami, Toshiaki Tachibana, Daiji Kawanami, Yasushi Kanazawa, Tamotsu Yokota, Kazunori Utsunomiya, and Rimei Nishimura
- Subjects
Biology (General) ,QH301-705.5 - Abstract
ROCK2 is found to be activated in 3 diabetic models and patients with diabetes. ROCK2 deletion in podocytes protects against diabetic kidney injury, with the beneficial effect of ROCK2 inhibition observed due to rescued PPARα signaling, leading to a recovery of fatty acid metabolism.
- Published
- 2022
- Full Text
- View/download PDF
8. Sparse Volume Rendering using Hardware Ray Tracing and Block Walking.
- Author
-
Mehmet Oguz Derin, Takahiro Harada, Yusuke Takeda, and Yasuhiro Iba
- Published
- 2021
- Full Text
- View/download PDF
9. Unraveling unique features of plasma cell clones in POEMS syndrome with single-cell analysis
- Author
-
Yusuke Isshiki, Motohiko Oshima, Naoya Mimura, Kensuke Kayamori, Yurie Miyamoto-Nagai, Masahide Seki, Yaeko Nakajima-Takagi, Takashi Kanamori, Eisuke Iwamoto, Tomoya Muto, Shokichi Tsukamoto, Yusuke Takeda, Chikako Ohwada, Sonoko Misawa, Jun-ichiro Ikeda, Masashi Sanada, Satoshi Kuwabara, Yutaka Suzuki, Emiko Sakaida, Chiaki Nakaseko, and Atsushi Iwama
- Subjects
Hematology ,Medicine - Abstract
POEMS syndrome is a rare monoclonal plasma cell disorder, with unique symptoms distinct from those of other plasma cell neoplasms, including high serum VEGF levels. Because the prospective isolation of POEMS clones has not yet been successful, their real nature remains unclear. Herein, we performed single-cell RNA-Seq of BM plasma cells from patients with POEMS syndrome and identified POEMS clones that had Ig λ light chain (IGL) sequences (IGLV1-36, -40, -44, and -47) with amino acid changes specific to POEMS syndrome. The proportions of POEMS clones in plasma cells were markedly smaller than in patients with multiple myeloma (MM) and patients with monoclonal gammopathy of undetermined significance (MGUS). Single-cell transcriptomes revealed that POEMS clones were CD19+, CD138+, and MHC class IIlo, which allowed for their prospective isolation. POEMS clones expressed significantly lower levels of c-MYC and CCND1 than MM clones, accounting for their small size. VEGF mRNA was not upregulated in POEMS clones, directly indicating that VEGF is not produced by POEMS clones. These results reveal unique features of POEMS clones and enhance our understanding of the pathogenesis of POEMS syndrome.
- Published
- 2022
- Full Text
- View/download PDF
10. Compression and Interactive Visualization of Terabyte Scale Volumetric RGBA Data with Voxel-scale Details.
- Author
-
Mehmet Oguz Derin, Takahiro Harada, Yusuke Takeda, and Yasuhiro Iba
- Published
- 2022
- Full Text
- View/download PDF
11. Myocyte-specific enhancer factor 2c triggers transdifferentiation of adipose tissue-derived stromal cells into spontaneously beating cardiomyocyte-like cells
- Author
-
Shinichiro Takashima, Soichiro Usui, Oto Inoue, Chiaki Goten, Kosei Yamaguchi, Yusuke Takeda, Shihe Cui, Yoshio Sakai, Kenshi Hayashi, Kenji Sakata, Masa-aki Kawashiri, and Masayuki Takamura
- Subjects
Medicine ,Science - Abstract
Abstract Cardiomyocyte regeneration is limited in adults. The adipose tissue-derived stromal vascular fraction (Ad-SVF) contains pluripotent stem cells that rarely transdifferentiate into spontaneously beating cardiomyocyte-like cells (beating CMs). However, the characteristics of beating CMs and the factors that regulate the differentiation of Ad-SVF toward the cardiac lineage are unknown. We developed a simple culture protocol under which the adult murine inguinal Ad-SVF reproducibly transdifferentiates into beating CMs without induction. The beating CMs showed the striated ventricular phenotype of cardiomyocytes and synchronised oscillation of the intracellular calcium concentration among cells on day 28 of Ad-SVF primary culture. We also identified beating CM-fated progenitors (CFPs) and performed single-cell transcriptome analysis of these CFPs. Among 491 transcription factors that were differentially expressed (≥ 1.75-fold) in CFPs and the beating CMs, myocyte-specific enhancer 2c (Mef2c) was key. Transduction of Ad-SVF cells with Mef2c using a lentiviral vector yielded CFPs and beating CMs with ~ tenfold higher cardiac troponin T expression, which was abolished by silencing of Mef2c. Thus, we identified the master gene required for transdifferentiation of Ad-SVF into beating CMs. These findings will facilitate the development of novel cardiac regeneration therapies based on gene-modified, cardiac lineage-directed Ad-SVF cells.
- Published
- 2021
- Full Text
- View/download PDF
12. The combination of the tubulin binding small molecule PTC596 and proteasome inhibitors suppresses the growth of myeloma cells
- Author
-
Yurie Nagai, Naoya Mimura, Ola Rizq, Yusuke Isshiki, Motohiko Oshima, Mohamed Rizk, Atsunori Saraya, Shuhei Koide, Yaeko Nakajima-Takagi, Makiko Miyota, Tetsuhiro Chiba, Nagisa Oshima-Hasegawa, Tomoya Muto, Shokichi Tsukamoto, Shio Mitsukawa, Yusuke Takeda, Chikako Ohwada, Masahiro Takeuchi, Tohru Iseki, Chiaki Nakaseko, William Lennox, Josephine Sheedy, Marla Weetall, Koutaro Yokote, Atsushi Iwama, and Emiko Sakaida
- Subjects
Medicine ,Science - Abstract
Abstract The novel small molecule PTC596 inhibits microtubule polymerization and its clinical development has been initiated for some solid cancers. We herein investigated the preclinical efficacy of PTC596 alone and in combination with proteasome inhibitors in the treatment of multiple myeloma (MM). PTC596 inhibited the proliferation of MM cell lines as well as primary MM samples in vitro, and this was confirmed with MM cell lines in vivo. PTC596 synergized with bortezomib or carfilzomib to inhibit the growth of MM cells in vitro. The combination treatment of PTC596 with bortezomib exerted synergistic effects in a xenograft model of human MM cell lines in immunodeficient mice and exhibited acceptable tolerability. Mechanistically, treatment with PTC596 induced cell cycle arrest at G2/M phase followed by apoptotic cell death, associated with the inhibition of microtubule polymerization. RNA sequence analysis also revealed that PTC596 and the combination with bortezomib affected the cell cycle and apoptosis in MM cells. Importantly, endoplasmic reticulum stress induced by bortezomib was enhanced by PTC596, providing an underlying mechanism of action of the combination therapy. Our results indicate that PTC596 alone and in combination with proteasome inhibition are potential novel therapeutic options to improve outcomes in patients with MM.
- Published
- 2021
- Full Text
- View/download PDF
13. Whole-brain propagating patterns in human resting-state brain activities
- Author
-
Yusuke Takeda, Nobuo Hiroe, and Okito Yamashita
- Subjects
Resting-state ,Whole-brain propagating activity ,Spatiotemporal pattern ,Resting-state network ,Magnetoencephalography (MEG) ,Electroencephalography (EEG) ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
Repetitive propagating activities in resting-state brain activities have been widely observed in various species and regions. Because they resemble the preceding brain activities during tasks, they are assumed to reflect past experiences embedded in neuronal circuits. “Whole-brain” propagating activities may also reflect a process that integrates information distributed over the entire brain, such as visual and motor information. Here we reveal whole-brain propagating activities from human resting-state magnetoencephalography (MEG) and electroencephalography (EEG) data. We simultaneously recorded the MEGs and EEGs and estimated the source currents from both measurements. Then using our recently proposed algorithm, we extracted repetitive spatiotemporal patterns from the source currents. The estimated patterns consisted of multiple frequency components, each of which transiently exhibited the frequency-specific resting-state networks (RSNs) of functional MRIs (fMRIs), such as the default mode and sensorimotor networks. A simulation test suggested that the spatiotemporal patterns reflected the phase alignment of the multiple frequency oscillators induced by the propagating activities along the anatomical connectivity. These results argue that whole-brain propagating activities transiently exhibited multiple RSNs in their multiple frequency components, suggesting that they reflected a process to integrate the information distributed over the frequencies and networks.
- Published
- 2021
- Full Text
- View/download PDF
14. Renal ROCK Activation and Its Pharmacological Inhibition in Patients With Diabetes
- Author
-
Keiichiro Matoba, Kensuke Sekiguchi, Yosuke Nagai, Yusuke Takeda, Hiroshi Takahashi, Tamotsu Yokota, Kazunori Utsunomiya, and Rimei Nishimura
- Subjects
Rho-kinase (ROCK) ,diabetic nephropathy ,chronic kidney disease ,diabetes ,cell signaling ,fasudil ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Rho-associated coiled-coil-containing protein kinase (ROCK) is a serine/threonine kinase with essential roles in cytoskeletal functions. Substantial evidence implicates ROCK as a critical regulator in the inception and progression of diabetic nephropathy through a mechanism involving mesangial fibrosis, podocyte apoptosis, and endothelial inflammation. Despite these experimental observations, human data is lacking. Here we show that the phosphorylated form of myosin phosphatase targeting subunit 1 (MYPT1), a ROCK substrate, was increased in both the glomerular and tubulointerstitial areas in patients with histologically confirmed diabetic nephropathy. We also conducted a retrospective pilot analysis of data from patients with diabetes to assess the renoprotective effects of fasudil, an ATP-competitive ROCK inhibitor licensed in Japan for the prevention of vasospasm following subarachnoid hemorrhage. Fifteen subjects (male, n = 8; female, n = 7; age 65.7 ± 14.7 years; body height, 161.1 ± 12.6 cm; body weight, 57.6 ± 13.7 kg; body mass index, 22.4 ± 3.7 kg/m2) were enrolled to evaluate blood pressure and the renal outcome after fasudil treatment. Of note, proteinuria was significantly reduced at the end of the fasudil treatment without affecting the blood pressure or estimated glomerular filtration rate. Taken together, these findings suggest that the administration of fasudil could be associated with a better renal outcome by inhibiting the ROCK activity in patients with diabetes.
- Published
- 2021
- Full Text
- View/download PDF
15. Fenestration without rib resection for postoperative bronchopleural fistula
- Author
-
Masatoshi Kanayama, Yoshinobu Ichiki, Katsuma Yoshimatsu, Yusuke Takeda, Kasumi Kusanagi, Teruaki Ishida, Masataka Mori, Hiroki Matsumiya, Yusuke Nabe, Akihiro Taira, Shinji Shinohara, Taiji Kuwata, Masaru Takenaka, Ayako Hirai, Naoko Imanishi, Kazue Yoneda, and Fumihiro Tanaka
- Subjects
Fenestration ,Without rib resection ,Postoperative bronchial fistula ,Surgery ,RD1-811 - Abstract
Abstract Background Fenestration is performed in patients with bronchopleural fistula to avoid a life-threatening situation. However, usually, this procedure is required 9-cm mean length of the incision with rib resection. Case presentation A 73-year-old man underwent right lower lobectomy with lymph node dissection (ND2a-2) for primary lung cancer (cT1cN2M0 Stage IIIA) with combined pulmonary fibrosis and emphysema. He developed a bronchopleural fistula on postoperative day 20, and we performed emergency fenestration without rib resection using a Lap-protector. The patient reported minimal pain postoperatively. As the rapid deterioration of the general condition due to the recurrence of the tumor was observed at the time of his 1-year postoperative follow-up, closing of the thoracic cavity was abandoned. However, using this fenestration, the control of infection in the thoracic cavity could be sufficiently performed without complications such as pain and pneumonia, and his routine activities were unaffected postoperatively. Conclusion Compared with conventional method, fenestration without rib resection using a Lap-protector is a more convenient and painless technique for postoperative bronchopleural fistula.
- Published
- 2019
- Full Text
- View/download PDF
16. Metastatic Orbital Tumor From Breast Ductal Carcinoma With Neuroendocrine Differentiation Initially Presenting as Ocular Symptoms: A Case Report and Literature Review
- Author
-
Keita Togashi, Koichi Nishitsuka, Shion Hayashi, Hiroyuki Namba, Sakiko Goto, Yusuke Takeda, Shuhei Suzuki, Tomoya Kato, Yuki Yamada, Eriko Konno, Takashi Yoshioka, Mitsunori Yamakawa, Yukihiko Sonoda, Tamio Suzuki, and Hidetoshi Yamashita
- Subjects
metastatic orbital tumor ,breast cancer ,neuroendocrine differentiation ,cytokeratin 7-negative ,visual function ,Diseases of the endocrine glands. Clinical endocrinology ,RC648-665 - Abstract
BackgroundOrbital metastases from cancers of various organs can arise via the hematogenous route, and many originate from breast, prostate, and lung cancers. Such metastatic orbital tumors may be diagnosed before the primary tumor. We have encountered a case of breast ductal carcinoma with neuroendocrine differentiation that metastasized to the orbit and responded to chemotherapy, with improvement in visual function.Case PresentationA woman in her fifties visited our ophthalmology department with a chief complaint of foreign body sensation and exophthalmos in her right eye. An elastic soft mass was palpated from the lateral orbit to the temporal region. A systemic examination revealed breast cancer and a metastatic orbital tumor. Excisional biopsy of the breast revealed a diagnosis of invasive ductal carcinoma with neuroendocrine differentiation, and immunohistochemical examination was negative for cytokeratin 7, making the case unusual. Chemotherapy was remarkably effective, and the tumor size decreased, resulting in improvement of visual function. Her general condition and quality of life are still good at present. We searched the PubMed English language literature focusing on metastatic orbital tumors from breast cancer in which ocular symptoms had been the initial presenting sign. No previous reports have documented neuroendocrine differentiation or cytokeratin 7 expression in isolated orbital metastases from breast cancer. Although it is not possible to be certain from this case alone, we speculated that some such cases might involve cytokeratin 7-negative invasive breast cancer with neuroendocrine differentiation.ConclusionWe have described our experience of a very rare case of cytokeratin 7 negative breast ductal carcinoma with neuroendocrine differentiation that metastasized to the orbit and formed a solitary giant tumor initially manifesting as ocular symptoms.
- Published
- 2021
- Full Text
- View/download PDF
17. Successful allogeneic bone marrow transplantation after massive gastrointestinal bleeding in a patient with myelodysplastic syndrome associated with intestinal Behçet-like disease
- Author
-
Arata Ishii, Shokichi Tsukamoto, Tatsuzo Mishina, Shintaro Izumi, Yurie Nagai, Miki Yamazaki, Yutaro Hino, Kensuke Kayamori, Nagisa Oshima-Hasegawa, Tomoya Muto, Shio Mitsukawa, Yusuke Takeda, Naoya Mimura, Chikako Ohwada, Chiaki Nakaseko, Jun-ichiro Ikeda, and Emiko Sakaida
- Subjects
Myelodysplastic syndrome ,Trisomy 8 ,Behçet-like disease ,Bone marrow transplantation ,Gastrointestinal bleeding ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
A 45-year-old woman was diagnosed with myelodysplastic syndrome (MDS) with trisomy 8 and Behçet-like disease (BLD) with multiple colorectal ulcers. Nonspecific inflammatory cells were infiltrated in the intestinal mucosa, whereas fluorescence in situ hybridization (FISH) analysis revealed only sporadic trisomy 8-positive cells. She presented massive lower gastrointestinal bleeding early after bone marrow transplantation but achieved long-term remission of both MDS and BLD. This is the first report of massive gastrointestinal bleeding after transplantation for MDS with BLD. Based on FISH analysis, dysregulation of systemic inflammation may be involved in BLD rather than direct invasion by trisomy 8-positive MDS clones.
- Published
- 2021
- Full Text
- View/download PDF
18. The Physiology, Pathology, and Therapeutic Interventions for ROCK Isoforms in Diabetic Kidney Disease
- Author
-
Keiichiro Matoba, Yusuke Takeda, Yosuke Nagai, Kensuke Sekiguchi, Tamotsu Yokota, Kazunori Utsunomiya, and Rimei Nishimura
- Subjects
notch ,hypoxia ,inflammation ,Rho (Rho GTPase) ,ROCK1/ROCK2 ,diabetic kidney disease (DKD) ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Rho-associated coiled-coil-containing protein kinase (ROCK) is a serine/threonine kinase that was originally identified as RhoA interacting protein. A diverse array of cellular functions, including migration, proliferation, and phenotypic modulation, are orchestrated by ROCK through a mechanism involving cytoskeletal rearrangement. Mammalian cells express two ROCK isoforms: ROCK1 (Rho-kinase β/ROKβ) and ROCK2 (Rho-kinase α/ROKα). While both isoforms have structural similarities and are widely expressed across multiple tissues, investigations in gene knockout animals and cell-based studies have revealed distinct functions of ROCK1 and ROCK2. With respect to the kidney, inhibiting ROCK activity has proven effective for the preventing diabetic kidney disease (DKD) in both type 1 and type 2 diabetic rodent models. However, despite significant progress in the understanding of the renal ROCK biology over the past decade, the pathogenic roles of the ROCK isoforms is only beginning to be elucidated. Recent studies have demonstrated the involvement of renal ROCK1 in mitochondrial dynamics and cellular transdifferentiation, whereas ROCK2 activation leads to inflammation, fibrosis, and cell death in the diabetic kidney. This review provides a conceptual framework for dissecting the molecular underpinnings of ROCK-driven renal injury, focusing on the differences between ROCK1 and ROCK2.
- Published
- 2020
- Full Text
- View/download PDF
19. Suppressive effects of anagrelide on cell cycle progression and the maturation of megakaryocyte progenitor cell lines in human induced pluripotent stem cells
- Author
-
Koji Takaishi, Masahiro Takeuchi, Shokichi Tsukamoto, Naoya Takayama, Motohiko Oshima, Kenji Kimura, Yusuke Isshiki, Kensuke Kayamori, Yutaro Hino, Nagisa Oshima-Hasegawa, Shio Mitsukawa, Yusuke Takeda, Naoya Mimura, Chikako Ohwada, Tohru Iseki, Sou Nakamura, Koji Eto, Atsushi Iwama, Koutaro Yokote, Chiaki Nakaseko, and Emiko Sakaida
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Published
- 2020
- Full Text
- View/download PDF
20. Estimating repetitive spatiotemporal patterns from many subjects' resting-state fMRIs.
- Author
-
Yusuke Takeda, Takashi Itahashi, Masa-aki Sato, and Okito Yamashita
- Published
- 2019
- Full Text
- View/download PDF
21. Web page revisiting by coordinate page discovery.
- Author
-
Yusuke Takeda, Hiroaki Ohshima, and Katsumi Tanaka
- Published
- 2015
- Full Text
- View/download PDF
22. A Reference Laboratory Surveillance on Fungal Isolates from Patients with Haematological Malignancy in Japan
- Author
-
Yutaro Hino, Akira Watanabe, Rio Seki, Shokichi Tsukamoto, Yusuke Takeda, Emiko Sakaida, and Katsuhiko Kamei
- Subjects
invasive fungal disease ,haematological disorder ,immunocompromised host ,Aspergillus ,Candida ,Fusarium ,Biology (General) ,QH301-705.5 - Abstract
Invasive fungal disease (IFD) in patients with haematological disorders is a fatal disease, making rapid identification and treatment crucial. However, the identification of the causative fungus is often difficult, sometimes even impossible. There have been few reports concerning the causative species of IFD. This study aimed to investigate the epidemiology and causative organism of IFD in patients with haematological diseases in Japan. We analyzed the IFD cases among the patients with haematological malignancies identified at the Medical Mycological Research Center, Chiba University, between 2013 and 2019. The most common underlying disease was acute myeloid leukaemia (34.3%). Forty-six point one percent of IFD patients received haematopoietic stem cell transplantation (HSCT). The major pathogens were Aspergillus, Candida, and Fusarium. Aspergillus fumigatus was the most common Aspergillus species, and Candida fermentati and Fusarium petroliphilum were the most common Candida and Fusarium species, respectively, in this analysis. Furthermore, various cryptic species and non-albicans Candida were identified. The drug susceptibility of such relatively rare strains suggests that analysis of the causative fungi should provide valuable information for therapeutic options. Therefore, our study indicated that it is clinically significant to identify the organism in as much detail as possible.
- Published
- 2021
- Full Text
- View/download PDF
23. Adaptive cardiac resynchronization therapy for dilated cardiomyopathy with functional mitral regurgitation
- Author
-
Yoshiki Nagata, MD, PhD, Yoichiro Nakagawa, MD, Yusuke Takeda, MD, Kenji Emoto, MD, Masaki Kinoshita, MD, Akio Chikata, MD, Michiro Maruyama, MD, PhD, and Kazuo Usuda, MD, PhD
- Subjects
Adaptive cardiac resynchronization therapy ,Functional mitral regurgitation ,Dilated cardiomyopathy ,Left ventricular pacing ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
We report the case of a man in his 60s who had dilated cardiomyopathy with severe functional mitral regurgitation. Four years after a cardiac resynchronization therapy (CRT) device with an implantable cardioverter defibrillator was implanted, this device was replaced with an adaptive CRT device because of battery consumption. Seven months after replacement of this device, the left ventricular pacing to right ventricular activation and the atrioventricular delay from automatic adjustments contributed to less functional mitral regurgitation. The findings from our case suggest that optimal CRT, by measuring intracardiac conduction parameters, is effective for functional mitral regurgitation.
- Published
- 2017
- Full Text
- View/download PDF
24. Dose-finding trial of azacitidine as post-transplant maintenance for high-risk MDS: a KSGCT prospective study
- Author
-
Yuho Najima, Takayoshi Tachibana, Yusuke Takeda, Yuya Koda, Yasuhisa Aoyama, Takashi Toya, Aiko Igarashi, Masatsugu Tanaka, Emiko Sakaida, Ryohei Abe, Makoto Onizuka, Takeshi Kobayashi, Noriko Doki, Kazuteru Ohashi, Heiwa Kanamori, Takuma Ishizaki, Akira Yokota, Satoshi Morita, Shinichiro Okamoto, and Yoshinobu Kanda
- Subjects
Adult ,Leukemia, Myeloid, Acute ,Myelodysplastic Syndromes ,Azacitidine ,Hematopoietic Stem Cell Transplantation ,Humans ,Prospective Studies ,Hematology ,General Medicine ,Middle Aged - Abstract
This 3+3 dose-escalation phase I multicenter study investigated the optimal dose of azacitidine (AZA) for post-hematopoietic stem cell transplantation (HSCT) maintenance, which remains unknown in Japan. Recipients of a first HSCT for high-risk myelodysplastic syndromes (MDS, n = 12) or acute myeloid leukemia (AML) with antecedent MDS (n = 3) received post-HSCT AZA maintenance in 2015-2019. The optimal AZA dose was defined as the dose at which 50-70% of patients can complete four cycles without dose-limiting toxicity (DLT). The initial dose level 1 was set as 30 mg/m
- Published
- 2022
- Full Text
- View/download PDF
25. Combined Therapy with Ixazomib, Lenalidomide, and Dexamethasone for Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome
- Author
-
Tomoki, Suichi, Sonoko, Misawa, Yukari, Sekiguchi, Kazumoto, Shibuya, Keigo, Nakamura, Hiroki, Kano, Yuya, Aotsuka, Ryo, Otani, Marie, Morooka, Shokichi, Tsukamoto, Yusuke, Takeda, Naoya, Mimura, Chikako, Ohwada, Emiko, Sakaida, and Satoshi, Kuwabara
- Subjects
Boron Compounds ,Vascular Endothelial Growth Factor A ,POEMS Syndrome ,Glycine ,Internal Medicine ,Humans ,General Medicine ,Endocrine System Diseases ,Lenalidomide ,Monoclonal Gammopathy of Undetermined Significance ,Dexamethasone - Abstract
Objective Immunomodulatory drugs and proteasome inhibitors are therapeutic options for polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome. This study aimed to evaluate the efficacy and safety of the combination of ixazomib, lenalidomide, and dexamethasone (IRd) for POEMS syndrome. Methods Six consecutive patients with POEMS syndrome who were treated with the IRd regimen at Chiba University Hospital between April 2018 and August 2021 were included. Serum M-protein and serum vascular endothelial growth factor (sVEGF) levels, overall neuropathy limitation scales (ONLS), clinical symptoms, and adverse events were assessed. Results Of the six patients, five had received prior treatments. Patients received a median of 5 cycles (range, 3-28 cycles) of IRd. Following treatment, serum M-protein disappeared in two patients, sVEGF levels returned to normal in two patients, two patients showed a reduction in the ONLS of 1, and clinical symptoms improved in four patients. The median level of sVEGF decreased from 2,395 pg/mL (range, 802-6,120 pg/mL) to 1,428 pg/mL (range, 183-3,680 pg/mL) in three months. Adverse events, including rash, neutropenia, sensory peripheral neuropathy, and nausea, were observed in three patients, which necessitated dose reduction or discontinuation of treatment. Conclusion IRd can be a therapeutic option for POEMS syndrome, albeit with careful monitoring of adverse events.
- Published
- 2022
- Full Text
- View/download PDF
26. Rho-associated, coiled-coil–containing protein kinase 1 regulates development of diabetic kidney disease via modulation of fatty acid metabolism
- Author
-
Yosuke Nagai, Keiichiro Matoba, Yusuke Takeda, Hideji Yako, Tomoyo Akamine, Kensuke Sekiguchi, Yasushi Kanazawa, Tamotsu Yokota, Kazunori Sango, Daiji Kawanami, Kazunori Utsunomiya, and Rimei Nishimura
- Subjects
Mice, Knockout ,Mice ,rho-Associated Kinases ,Nephrology ,Fatty Acids ,Diabetes Mellitus ,Animals ,Diabetic Nephropathies ,Lipid Metabolism ,Signal Transduction - Abstract
Dysregulation of fatty acid utilization is increasingly recognized as a significant component of diabetic kidney disease. Rho-associated, coiled-coil-containing protein kinase (ROCK) is activated in the diabetic kidney, and studies over the past decade have illuminated ROCK signaling as an essential pathway in diabetic kidney disease. Here, we confirmed the distinct role of ROCK1, an isoform of ROCK, in fatty acid metabolism using glomerular mesangial cells and ROCK1 knockout mice. Mesangial cells with ROCK1 deletion were protected from mitochondrial dysfunction and redox imbalance driven by transforming growth factor β, a cytokine upregulated in diabetic glomeruli. We found that high-fat diet-induced obese ROCK1 knockout mice exhibited reduced albuminuria and histological abnormalities along with the recovery of impaired fatty acid utilization and mitochondrial fragmentation. Mechanistically, we found that ROCK1 regulates the induction of critical mediators in fatty acid metabolism, including peroxisome proliferator-activated receptor gamma coactivator 1α, carnitine palmitoyltransferase 1, and widespread program-associated cellular metabolism. Thus, our findings highlight ROCK1 as an important regulator of energy homeostasis in mesangial cells in the overall pathogenesis of diabetic kidney disease.
- Published
- 2022
- Full Text
- View/download PDF
27. MEG Source Imaging and Group Analysis Using VBMEG
- Author
-
Yusuke Takeda, Keita Suzuki, Mitsuo Kawato, and Okito Yamashita
- Subjects
VBMEG ,MEG ,EEG ,fMRI ,source imaging ,source reconstruction ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
Variational Bayesian Multimodal EncephaloGraphy (VBMEG) is a MATLAB toolbox that estimates distributed source currents from magnetoencephalography (MEG)/electroencephalography (EEG) data by integrating functional MRI (fMRI) (https://vbmeg.atr.jp/). VBMEG also estimates whole-brain connectome dynamics using anatomical connectivity derived from a diffusion MRI (dMRI). In this paper, we introduce the VBMEG toolbox and demonstrate its usefulness. By collaborating with VBMEG's tutorial page (https://vbmeg.atr.jp/docs/v2/static/vbmeg2_tutorial_neuromag.html), we show its full pipeline using an open dataset recorded by Wakeman and Henson (2015). We import the MEG data and preprocess them to estimate the source currents. From the estimated source currents, we perform a group analysis and examine the differences of current amplitudes between conditions by controlling the false discovery rate (FDR), which yields results consistent with previous studies. We highlight VBMEG's characteristics by comparing these results with those obtained by other source imaging methods: weighted minimum norm estimate (wMNE), dynamic statistical parametric mapping (dSPM), and linearly constrained minimum variance (LCMV) beamformer. We also estimate source currents from the EEG data and the whole-brain connectome dynamics from the MEG data and dMRI. The observed results indicate the reliability, characteristics, and usefulness of VBMEG.
- Published
- 2019
- Full Text
- View/download PDF
28. Detection of MYD88 L265P mutation by next-generation deep sequencing in peripheral blood mononuclear cells of Waldenström's macroglobulinemia and IgM monoclonal gammopathy of undetermined significance.
- Author
-
Ayako Nakamura, Chikako Ohwada, Masahiro Takeuchi, Yusuke Takeda, Shokichi Tsukamoto, Naoya Mimura, Oshima-Hasegawa Nagisa, Yasumasa Sugita, Hiroaki Tanaka, Hisashi Wakita, Nobuyuki Aotsuka, Kosei Matsue, Koutaro Yokote, Osamu Ohara, Chiaki Nakaseko, and Emiko Sakaida
- Subjects
Medicine ,Science - Abstract
We investigated the feasibility of using next-generation sequencing (NGS) technique using molecular barcoding technology to detect MYD88 L265P mutation in unselected peripheral blood mononuclear cells (PBMCs) in 52 patients with Waldenström's macroglobulinemia [1] and 21 patients with IgM-monoclonal gammopathy of undetermined significance (MGUS). The NGS technique successfully detected the MYD88 L265P in unselected PBMCs at a sensitivity of 0.02%, which was ×5 higher than that of AS-PCR. All the results between paired BM and PB samples from 2 IgM MGUS and 4 untreated WM patients matched completely. MYD88 L265P mutation was detected in 14/21 (66.7%), 14/19 (73.7%), and 10/33 (30.3%) with the median mutant allele burden of 0.36% (range, 0.06-2.85%), 0.48% (range, 0.02-32.3%), and 0.16% (range, 0.02-33.8%), in IgM-MGUS, untreated WM, and previously treated WM, respectively. Multiple linear regression analysis identified an absolute peripheral lymphocyte count as the positive predictor of PB mutant allele burden (R2 = 0,72, P
- Published
- 2019
- Full Text
- View/download PDF
29. Estimating repetitive spatiotemporal patterns from resting-state brain activity data.
- Author
-
Yusuke Takeda, Nobuo Hiroe, Okito Yamashita, and Masa-aki Sato
- Published
- 2016
- Full Text
- View/download PDF
30. Quadrant Dynamic Programming for Optimizing Velocity of Ecological Adaptive Cruise Control
- Author
-
Osamu Shimizu, Takuma Nagashio, Koji Sato, Yusuke Takeda, Mitsuhiro Hattori, Sakahisa Nagai, and Hiroshi Fujimoto
- Subjects
business.product_category ,Computer science ,Ecology ,Computation ,Energy consumption ,Computer Science Applications ,Vehicle dynamics ,Dynamic programming ,Model predictive control ,Control and Systems Engineering ,Electric vehicle ,Table (database) ,Electrical and Electronic Engineering ,business ,Cruise control - Abstract
Previous studies have proposed various algorithms such as model predictive control, machine learning, and dynamic programming for ecological adaptive cruise control (ACC). However, industrial application of these algorithms is limited owing to their considerable computational cost. Moreover, there is a tradeoff between the calculation time and optimization results. In this study, a novel optimization method, referred to as quadrant dynamic programming (QDP), for ACC is proposed. QDP is based on regular dynamic programming (DP); it divides the DP table into four quadrants. Most of the computations are performed offline, and expensive hardware is not required to be installed in vehicles. Moreover, the offline computation cost is also reduced to a practical level, whereas the result is globally optimal. The algorithm is validated for reducing the energy consumption of an electric vehicle (EV) via simulations and experiments using our test vehicle. The experimental results also showed the accuracy of the motor and vehicle dynamics models. Compared with the widely used ACC for feedback control, QDP reduced energy consumption by 16.1 % in multi-lane car following scenarios with the same cruising distance and time. The proposed QDP avoided trade-offs between computational cost and optimization results by utilizing offline computation effectively. Moreover, it was proven valid for general ecological ACC applications.
- Published
- 2022
- Full Text
- View/download PDF
31. Three cases of anomalous posterior segmental vein (V2) in upper lobe of right lung
- Author
-
Yusuke Takeda, Makoto Nakagawa, and Kenichi Kobayashi
- Published
- 2022
- Full Text
- View/download PDF
32. Immunogenicity and safety of routine 13-valent pneumococcal conjugate vaccination outside recommended age range in patients with hematological malignancies and solid tumors
- Author
-
Kenichi, Takeshita, Naruhiko, Ishiwada, Noriko, Takeuchi, Misako, Ohkusu, Mihoko, Ohata, Moeko, Hino, Haruka, Hishiki, Yusuke, Takeda, Emiko, Sakaida, Yoshiko, Takahashi, Naoki, Shimojo, and Hiromichi, Hamada
- Subjects
Vaccines, Conjugate ,General Veterinary ,General Immunology and Microbiology ,Vaccination ,Public Health, Environmental and Occupational Health ,Infant ,Antibodies, Bacterial ,Pneumococcal Infections ,Pneumococcal Vaccines ,Infectious Diseases ,Hematologic Neoplasms ,Neoplasms ,Humans ,Molecular Medicine - Abstract
Hematological malignancy and solid tumor are major risks for invasive pneumococcal disease. Thirteen-valent pneumococcal conjugate vaccine (PCV13) is recommended for immunocompromised patients aged 6 years and older and adults who had not received the vaccine previously. However, vaccination for these individuals is not publicly subsidized in Japan. We measured pneumococcal serotype-specific IgGs (Pn-IgGs) and opsonophagocytic activities (Pn-OPAs) against PCV13 serotypes (1, 3, 5, 6A, 7F, and 19A) in patients with hematological malignancies and solid tumors who were outside the recommended age range for routine vaccination at baseline and at 1 and 6 months after the first dose of PCV13. Pneumococcal serotype-specific memory B cells (Pn-MBCs) against serotype 3 were measured from a portion of the study samples. Thirty-seven patients (30 in the young patient group and 7 in the adult patient group) completed the study. Pn-IgGs were significantly elevated at 1 month post-vaccination and persisted in protection level for 6 months after the first vaccination against all six serotypes measured except serotype 3. Pn-OPAs were significantly elevated and persisted as well against all six serotypes. Pn-MBCs were measured in 10 patients, and 90% of them had at least one detectable Pn-MBC, and 70% of them showed an increased frequency of Pn-MBCs against serotype 3. No serious adverse events were observed up to 1 month after vaccination. PCV13 is thus safe and immunogenic, including against serotype 3, in patients with hematological malignancies and solid tumors outside the recommended age range for routine vaccination.
- Published
- 2022
- Full Text
- View/download PDF
33. Single cell transcriptomics identifies adipose tissue CD271+ progenitors for enhanced angiogenesis in limb ischemia
- Author
-
Oto Inoue, Chiaki Goten, Daiki Hashimuko, Kosei Yamaguchi, Yusuke Takeda, Ayano Nomura, Hiroshi Ootsuji, Shinichiro Takashima, Kenji Iino, Hirofumi Takemura, Manasi Halurkar, Hee-Woong Lim, Vivian Hwa, Joan Sanchez-Gurmaches, Soichiro Usui, and Masayuki Takamura
- Subjects
Article - Abstract
SUMMARYTherapeutic angiogenesis using mesenchymal stem/stromal cell grafts have shown modest and controversial effects in preventing amputation for patients with critical limb ischemia. Through single-cell transcriptomic analysis of human tissues, we identified CD271+progenitors specifically from subcutaneous adipose tissue (AT) as having the most prominent pro-angiogenic gene profile distinct from other stem cell populations. AT-CD271+progenitors demonstrated robustin vivoangiogenic capacity, over conventional adipose stromal cell grafts, characterized by long-term engraftment, augmented tissue regeneration, and significant recovery of blood flow in a xenograft model of limb ischemia. Mechanistically, the angiogenic capacity of CD271+progenitors is dependent on functional CD271 and mTOR signaling. Notably, the number and angiogenic capacity of CD271+progenitors was strikingly reduced in insulin resistant donors. Our study highlights the identification of AT-CD271+progenitors within vivosuperior efficacy for limb ischemia. Furthermore, we showcase comprehensive single-cell transcriptomics strategies for identification of suitable grafts for cell therapy.HIGHLIGHTSAdipose tissue stromal cells have a distinct angiogenic gene profile among human cell sources.CD271+progenitors in adipose tissue have a prominent angiogenic gene profile.CD271+progenitors show superior therapeutic capacities for limb ischemia.CD271+progenitors are reduced and functionally impaired in insulin resistant donors.GRAPHICAL ABSTRACT
- Published
- 2023
34. Lung Autotransplantation for Bulky Superior Sulcus Tumor With Hilar Involvement
- Author
-
Akihiro Taira, Ayako Nawashiro, Yusuke Takeda, Shinji Shinohara, Masaru Takenaka, Koji Kuroda, Takahiro Oto, and Fumihiro Tanaka
- Subjects
Pulmonary and Respiratory Medicine ,Surgery ,Cardiology and Cardiovascular Medicine - Published
- 2022
- Full Text
- View/download PDF
35. Endothelial Dysfunction in Diabetes
- Author
-
Yusuke Takeda, Keiichiro Matoba, Kensuke Sekiguchi, Yosuke Nagai, Tamotsu Yokota, Kazunori Utsunomiya, and Rimei Nishimura
- Subjects
endothelial dysfunction ,insulin resistance ,macrophage polarity ,Biology (General) ,QH301-705.5 - Abstract
Diabetes is a worldwide health issue closely associated with cardiovascular events. Given the pandemic of obesity, the identification of the basic underpinnings of vascular disease is strongly needed. Emerging evidence has suggested that endothelial dysfunction is a critical step in the progression of atherosclerosis. However, how diabetes affects the endothelium is poorly understood. Experimental and clinical studies have illuminated the tight link between insulin resistance and endothelial dysfunction. In addition, macrophage polarization from M2 towards M1 contributes to the process of endothelial damage. The possibility that novel classes of anti-hyperglycemic agents exert beneficial effects on the endothelial function and macrophage polarization has been raised. In this review, we discuss the current status of knowledge regarding the pathological significance of insulin signaling in endothelium. Finally, we summarize recent therapeutic strategies against endothelial dysfunction with an emphasis on macrophage polarity.
- Published
- 2020
- Full Text
- View/download PDF
36. Targeting Redox Imbalance as an Approach for Diabetic Kidney Disease
- Author
-
Keiichiro Matoba, Yusuke Takeda, Yosuke Nagai, Tamotsu Yokota, Kazunori Utsunomiya, and Rimei Nishimura
- Subjects
diabetic kidney disease ,oxidative stress ,redox imbalance ,Biology (General) ,QH301-705.5 - Abstract
Diabetic kidney disease (DKD) is a worldwide public health problem. It is the leading cause of end-stage renal disease and is associated with increased mortality from cardiovascular complications. The tight interactions between redox imbalance and the development of DKD are becoming increasingly evident. Numerous cascades, including the polyol and hexosamine pathways have been implicated in the oxidative stress of diabetes patients. However, the precise molecular mechanism by which oxidative stress affects the progression of DKD remains to be elucidated. Given the limited therapeutic options for DKD, it is essential to understand how oxidants and antioxidants are controlled in diabetes and how oxidative stress impacts the progression of renal damage. This review aims to provide an overview of the current status of knowledge regarding the pathological roles of oxidative stress in DKD. Finally, we summarize recent therapeutic approaches to preventing DKD with a focus on the anti-oxidative effects of newly developed anti-hyperglycemic agents.
- Published
- 2020
- Full Text
- View/download PDF
37. Dynamic Information Flow Based on EEG and Diffusion MRI in Stroke: A Proof-of-Principle Study
- Author
-
Olena G. Filatova, Yuan Yang, Julius P. A. Dewald, Runfeng Tian, Pablo Maceira-Elvira, Yusuke Takeda, Gert Kwakkel, Okito Yamashita, and Frans C. T. van der Helm
- Subjects
EEG ,diffusion MRI ,somatosensory evoked potentials (SEP) ,brain dynamics ,stroke ,Neurosciences. Biological psychiatry. Neuropsychiatry ,RC321-571 - Abstract
In hemiparetic stroke, functional recovery of paretic limb may occur with the reorganization of neural networks in the brain. Neuroimaging techniques, such as magnetic resonance imaging (MRI), have a high spatial resolution which can be used to reveal anatomical changes in the brain following a stroke. However, low temporal resolution of MRI provides less insight of dynamic changes of brain activity. In contrast, electro-neurophysiological techniques, such as electroencephalography (EEG), have an excellent temporal resolution to measure such transient events, however are hindered by its low spatial resolution. This proof-of-principle study assessed a novel multimodal brain imaging technique namely Variational Bayesian Multimodal Encephalography (VBMEG), which aims to improve the spatial resolution of EEG for tracking the information flow inside the brain and its changes following a stroke. The limitations of EEG are complemented by constraints derived from anatomical MRI and diffusion weighted imaging (DWI). EEG data were acquired from individuals suffering from a stroke as well as able-bodied participants while electrical stimuli were delivered sequentially at their index finger in the left and right hand, respectively. The locations of active sources related to this stimulus were precisely identified, resulting in high Variance Accounted For (VAF above 80%). An accurate estimation of dynamic information flow between sources was achieved in this study, showing a high VAF (above 90%) in the cross-validation test. The estimated dynamic information flow was compared between chronic hemiparetic stroke and able-bodied individuals. The results demonstrate the feasibility of VBMEG method in revealing the changes of information flow in the brain after stroke. This study verified the VBMEG method as an advanced computational approach to track the dynamic information flow in the brain following a stroke. This may lead to the development of a quantitative tool for monitoring functional changes of the cortical neural networks after a unilateral brain injury and therefore facilitate the research into, and the practice of stroke rehabilitation.
- Published
- 2018
- Full Text
- View/download PDF
38. Low durophagous predation on Toarcian (Early Jurassic) ammonoids in the northwestern Panthalassa shelf basin
- Author
-
Yusuke Takeda and Kazushige Tanabe
- Subjects
Ammonoids ,predation ,ventral bite marks ,Jurassic ,Toarcian ,Panthalassa ,Fossil man. Human paleontology ,GN282-286.7 ,Paleontology ,QE701-760 - Abstract
Predatory shell breakage is known to occur occasionally on the ventrolateral portion of the body chamber in Mesozoic ammonoids. Here we report, for the first time, quantitative data of shell breakage in large ammonoid samples that were recovered from the lower Toarcian (Lower Jurassic) strata in the Toyora area, western Japan. The strata yielding the ammonoid samples consisted mostly of well-laminated, bituminous black shale that was deposited in an oxygen-depleted shelf basin of the northwestern Panthalassa, under the influence of the early Toarcian oceanic anoxic event. Among a total of 1305 specimens from 18 localities, apparent shell breakage was recognised in 35 specimens belonging to 7 genera, resulting in only a 2.7% frequency of occurrence relative to the total number of specimens. The breakage occurs mostly on the ventrolateral side of the body chamber with a complete shell aperture. This fact, as well as the low energy bottom condition suggested for the ammonoid-bearing shale, indicate that the shell breaks observed in the examined ammonoids were not produced by non-biological, post-mortem biostratinomical processes but were lethal injuries inflicted by nektonic predators such as reptiles, jawed fishes, coleoids, nautiloids, and carnivorous ammonoids with calcified rostral tips in their upper and lower jaws. Similar predatory shell breaks on the ventrolateral side of the body chamber have been found in contemporaneous ammonoid assemblages of the Tethys Realm, with a much higher frequency of occurrence than in the examined samples from the northwestern Panthalassa, suggesting a weaker durophagous predation pressure on ammonoids in the latter bioprovince.
- Published
- 2015
- Full Text
- View/download PDF
39. Effect of Electric Field on the Hydrodynamic Assembly of Polydisperse and Entangled Fibrillar Suspensions
- Author
-
L. Daniel Söderberg, Tomas Rosén, Hidemasa Takana, Christophe Brouzet, Fredrik Lundell, Nitesh Mittal, and Yusuke Takeda
- Subjects
Materials science ,Nanostructure ,Field (physics) ,Microfluidics ,Nanotechnology ,02 engineering and technology ,010402 general chemistry ,01 natural sciences ,Suspension (chemistry) ,law.invention ,Electricity ,Suspensions ,law ,Electric field ,Electrochemistry ,General Materials Science ,Cellulose ,Nanoscopic scale ,Spectroscopy ,Surfaces and Interfaces ,021001 nanoscience & nanotechnology ,Condensed Matter Physics ,0104 chemical sciences ,Electrode ,Hydrodynamics ,0210 nano-technology ,Alternating current - Abstract
Dynamics of colloidal particles can be controlled by the application of electric fields at micrometer-nanometer length scales. Here, an electric field-coupled microfluidic flow-focusing device is designed for investigating the effect of an externally applied alternating current (AC) electric field on the hydrodynamic assembly of cellulose nanofibrils (CNFs). We first discuss how the nanofibrils align parallel to the direction of the applied field without flow. Then, we apply an electric field during hydrodynamic assembly in the microfluidic channel and observe the effects on the mechanical properties of the assembled nanostructures. We further discuss the nanoscale orientational dynamics of the polydisperse and entangled fibrillar suspension of CNFs in the channel. It is shown that electric fields induced with the electrodes locally increase the degree of orientation. However, hydrodynamic alignment is demonstrated to be much more efficient than the electric field for aligning CNFs. The results are useful for understanding the development of the nanostructure when designing high-performance materials with microfluidics in the presence of external stimuli.
- Published
- 2021
- Full Text
- View/download PDF
40. Myocyte-specific enhancer factor 2c triggers transdifferentiation of adipose tissue-derived stromal cells into spontaneously beating cardiomyocyte-like cells
- Author
-
Masa-aki Kawashiri, Soichiro Usui, Shinichiro Takashima, Masayuki Takamura, Kenji Sakata, Kenshi Hayashi, Shihe Cui, Oto Inoue, Kosei Yamaguchi, Yusuke Takeda, Chiaki Goten, and Yoshio Sakai
- Subjects
0301 basic medicine ,Male ,Pluripotent Stem Cells ,Stromal cell ,Science ,Adipose tissue ,Stem-cell differentiation ,030204 cardiovascular system & hematology ,Biology ,Article ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Animals ,MEF2C ,Myocytes, Cardiac ,Progenitor cell ,Induced pluripotent stem cell ,Cells, Cultured ,health care economics and organizations ,Cell Proliferation ,Adult stem cells ,Multidisciplinary ,MEF2 Transcription Factors ,Regeneration (biology) ,Transdifferentiation ,Reprogramming ,Cell Differentiation ,Mesenchymal Stem Cells ,Stromal vascular fraction ,Cell biology ,Mice, Inbred C57BL ,030104 developmental biology ,Adipose Tissue ,Cell Transdifferentiation ,cardiovascular system ,Medicine ,Female ,Stromal Cells - Abstract
Cardiomyocyte regeneration is limited in adults. The adipose tissue-derived stromal vascular fraction (Ad-SVF) contains pluripotent stem cells that rarely transdifferentiate into spontaneously beating cardiomyocyte-like cells (beating CMs). However, the characteristics of beating CMs and the factors that regulate the differentiation of Ad-SVF toward the cardiac lineage are unknown. We developed a simple culture protocol under which the adult murine inguinal Ad-SVF reproducibly transdifferentiates into beating CMs without induction. The beating CMs showed the striated ventricular phenotype of cardiomyocytes and synchronised oscillation of the intracellular calcium concentration among cells on day 28 of Ad-SVF primary culture. We also identified beating CM-fated progenitors (CFPs) and performed single-cell transcriptome analysis of these CFPs. Among 491 transcription factors that were differentially expressed (≥ 1.75-fold) in CFPs and the beating CMs, myocyte-specific enhancer 2c (Mef2c) was key. Transduction of Ad-SVF cells with Mef2c using a lentiviral vector yielded CFPs and beating CMs with ~ tenfold higher cardiac troponin T expression, which was abolished by silencing of Mef2c. Thus, we identified the master gene required for transdifferentiation of Ad-SVF into beating CMs. These findings will facilitate the development of novel cardiac regeneration therapies based on gene-modified, cardiac lineage-directed Ad-SVF cells.
- Published
- 2021
41. Exhausted T Cells Characterized By Upregulation of Specific Transcription Factors Are Increased in a Mouse Model of De Novo Mature B Cell Neoplasms
- Author
-
Asuka Shibamiya, Naoya Mimura, Yurie Miyamoto-Nagai, Shuhei Koide, Motohiko Oshima, Ola Rizq, Kazumasa Aoyama, Yaeko Nakajima-Takagi, Kensuke Kayamori, Yusuke Isshiki, Nagisa Oshima-Hasegawa, Tomoya Muto, Shokichi Tsukamoto, Yusuke Takeda, Ryo Koyama-Nasu, Tetsuhiro Chiba, Hiroaki Honda, Koutaro Yokote, Atsushi Iwama, and Emiko Sakaida
- Subjects
Immunology ,Cell Biology ,Hematology ,Biochemistry - Published
- 2022
- Full Text
- View/download PDF
42. 386-P: ROCK1 Regulation of AMPK in the Development of Diabetic Nephropathy
- Author
-
YOSUKE NAGAI, KEIICHIRO MATOBA, KENSUKE SEKIGUCHI, YUSUKE TAKEDA, YASUSHI KANAZAWA, DAIJI KAWANAMI, KAZUNORI UTSUNOMIYA, and RIMEI NISHIMURA
- Subjects
Endocrinology, Diabetes and Metabolism ,Internal Medicine - Abstract
Rho-associated, coiled-coil-containing protein kinase (ROCK) is activated in the diabetic kidney. Studies over the past decade have illuminated ROCK signaling as an essential pathway in the pathogenesis of diabetic nephropathy. Accumulating evidence shows that renal dysfunction among patient with diabetes is associated with abnormal fatty acid oxidation in the kidney. However, the interaction of ROCK and fatty acid oxidation in diabetic kidneys remains unclear. Extracellular flux analyzer demonstrated that deficiency of ROCK1, one of the ROCK isoforms, improves TGF-β-induced mitochondrial dysfunction in primary cultured mesangial cells. ROCK1 deficiency rescued TGF-β-induced downregulation of fatty acid oxidation mediators such as peroxisome proliferator-activated receptor gamma coactivator 1-α (PGC-1α) , and carnitine palmitoyltransferase 1A (CPT1A) . An investigation of mechanisms underlying this observation revealed activated ROCK1 axis through the phosphorylation of AMPK and increased expression of PGC-1α. Fluorescence histochemistry showed that ROCK1 deficiency suppresses ROS production induced by mitochondrial damage due to abnormal fatty acid metabolism. Consistent with this result, compared to wild-type mice, ROCK1 knockout mice exhibited reduced albuminuria and histological abnormalities along with the recovery of impaired fatty acid utilization and mitochondrial fragmentation. Furthermore, RNA-seq showed that ROCK1 deficiency in mesangial cells significantly altered the expression of genes involved in metabolic pathway. These observations indicate that ROCK1 is a key player in the development of diabetic renal injury. ROCK1 may be a potential therapeutic target for the treatment of diabetic nephropathy. Disclosure Y.Nagai: None. K.Matoba: None. K.Sekiguchi: None. Y.Takeda: None. Y.Kanazawa: None. D.Kawanami: None. K.Utsunomiya: None. R.Nishimura: Speaker's Bureau; Abbott Diabetes, Astellas Pharma Inc., AstraZeneca, Boehringer Ingelheim International GmbH, Eli Lilly and Company, Medtronic, Merck & Co., Inc., Novo Nordisk, Ono Pharmaceutical Co., Ltd., Sanofi, Taisho Pharmaceutical Holdings Co., Ltd., Takeda Pharmaceutical Company Limited, Teijin Pharma Limited, Terumo Corporation.
- Published
- 2022
- Full Text
- View/download PDF
43. 388-P: Renal ROCK2 Activity in Folic Acid-Induced Nephropathy
- Author
-
KENSUKE SEKIGUCHI, KEIICHIRO MATOBA, RIKAKO UKICHI, YOSUKE NAGAI, YUSUKE TAKEDA, YASUSHI KANAZAWA, KAZUNORI UTSUNOMIYA, and RIMEI NISHIMURA
- Subjects
Endocrinology, Diabetes and Metabolism ,Internal Medicine - Abstract
The small GTPase Rho and its effector Rho-kinase (ROCK) are involved in the pathogenesis of diabetic nephropathy. In chronic kidney diseases including diabetic nephropathy, tubulointerstitial fibrosis is closely related to renal outcome. We have previously reported that ROCK inhibition suppressed the progression of diabetic nephropathy in murine models. ROCK has two isoforms, ROCK1 and ROCK2. ROCK1 is known to be involved in the endocytosis of albumin in tubular epithelial cells via megalin/cubilin-dependent mechanism. On the other hand, the role of renal tubular ROCK2 has not been elucidated.In the present study, we aimed to establish the role of renal tubular ROCK2 in the pathogenesis of chronic kidney disease using a tubulointerstitial injury model known as folic acid-induced nephropathy (FAN) . Masson’s trichrome staining showed an elevated collagen deposition in the kidneys of FAN group compared with vehicle-treated group. We detected a relative upregulation of ROCK2 at protein levels in FAN group, compared with vehicle-treated group. Immunoprecipitation assay demonstrated that the kinase activity of ROCK2 relatively increased in FAN group. Based on these findings, we conclude that ROCK2 has an important contribution to tubulointerstitial fibrosis. ROCK2 may become a therapeutic target for the treatment of chronic kidney disease. Disclosure K.Sekiguchi: None. K.Matoba: None. R.Ukichi: None. Y.Nagai: None. Y.Takeda: None. Y.Kanazawa: None. K.Utsunomiya: None. R.Nishimura: Speaker's Bureau; Abbott Diabetes, Astellas Pharma Inc., AstraZeneca, Boehringer Ingelheim International GmbH, Eli Lilly and Company, Medtronic, Merck & Co., Inc., Novo Nordisk, Ono Pharmaceutical Co., Ltd., Sanofi, Taisho Pharmaceutical Holdings Co., Ltd., Takeda Pharmaceutical Company Limited, Teijin Pharma Limited, Terumo Corporation.
- Published
- 2022
- Full Text
- View/download PDF
44. 6-OR: Vascular Endothelial ROCK2 Deficiency Promotes Browning and Burning of White Adipose Tissue
- Author
-
YUSUKE TAKEDA, KEIICHIRO MATOBA, RIKAKO UKICHI, KENSUKE SEKIGUCHI, YOSUKE NAGAI, YASUSHI KANAZAWA, KAZUNORI UTSUNOMIYA, and RIMEI NISHIMURA
- Subjects
Endocrinology, Diabetes and Metabolism ,Internal Medicine - Abstract
The accumulation of visceral fat is associated with multiple coronary risk factors such as glucose intolerance, dyslipidemia, and hypertension. We have previously demonstrated that Rho/Rho-associated protein kinase (ROCK) signaling is activated in animal models of diabetes and is involved in the pathogenesis of vascular complications. Specifically, ROCK is implicated in the molecular basis of inflammation- and ischemia-induced tissue damage through the actions on NF-κB dynamics. These findings support the hypothesis that ROCK signaling could be one of the important therapeutic targets for preventing cardiorenal events. However, isoform-specific roles of ROCKs have not been clarified yet. In this study, we aimed to determine the tissue-intrinsic roles of ROCK2 in the setting of obesity. To this end, we generated vascular endothelium-specific ROCK2 knockout mice (ER2KO) by crossing ROCK2 floxed mice with VE-Cadherin-Cre mice. ER2KO mice were fertile and had the same lifespan as wild type mice. Notably, ER2KO gained weight at a slower rate than wild type mice under high-fat diet feeding. Fat composition, as assessed by magnetic resonance imaging, was significantly lower in ER2KO, even though ER2KO displayed increased food intake. The gene expression analysis revealed increased expression of PPARα, a browning-inducing factor, and its downstream components, CIDEA, IL-4, and IL-10, in white adipose tissue obtained from ER2KO mice. ER2KO mice also showed an elevation in body temperature after fasting, suggesting that endothelial ROCK2 may negatively regulate fat browning. In summary, vascular endothelial ROCK2 negatively regulates fat accumulation through the mechanism of browning inhibition. Disclosure Y. Takeda: None. K. Matoba: None. R. Ukichi: None. Y. Nagai: None. Y. Kanazawa: None. K. Utsunomiya: None. R. Nishimura: Speaker's Bureau; Abbott Diabetes, Astellas Pharma Inc., AstraZeneca, Boehringer Ingelheim International GmbH, Eli Lilly and Company, Medtronic, Merck & Co., Inc., Novo Nordisk, Ono Pharmaceutical Co., Ltd., Sanofi, Taisho Pharmaceutical Holdings Co., Ltd., Takeda Pharmaceutical Company Limited, Teijin Pharma Limited, Terumo Corporation. Funding a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science, the MSD Life Science Foundation, the Takeda Science Foundation, the Suzuken Memorial Foundation, Sanofi KK, Tanabe Pharma, and Takeda Pharmaceutical., Kazunori Utsunomiya has received research support from Terumo, Novo Nordisk Pharma, Taisho Pharmaceutical, Böehringer Ingelheim, Kyowa Hakko Kirin, Sumitomo Dainippon Pharma, and OPharmaceutical as, Rimei Nishimura has received speaker honoraria from Astellas Pharma, Nippon Boehringer Ingelheim, Eli Lilly Japan KK, Kissei Pharmaceutical, Medtronic Japan, MSD, Novartis Pharma KK, Novo Nordisk Phar.
- Published
- 2022
- Full Text
- View/download PDF
45. Cortical current source estimation from electroencephalography in combination with near-infrared spectroscopy as a hierarchical prior.
- Author
-
Takatsugu Aihara, Yusuke Takeda, Kotaro Takeda, Wataru Yasuda, Takanori Sato, Yohei Otaka, Takashi Hanakawa, Manabu Honda, Meigen Liu, Mitsuo Kawato, Masa-aki Sato, and Rieko Osu
- Published
- 2012
- Full Text
- View/download PDF
46. A generalized method to estimate waveforms common across trials from EEGs.
- Author
-
Yusuke Takeda, Masa-aki Sato, Kentaro Yamanaka, Daichi Nozaki, and Yoshiharu Yamamoto
- Published
- 2010
- Full Text
- View/download PDF
47. Pharmacokinetics of intravenous busulfan as condition for hematopoietic stem cell transplantation: comparison between combinations with cyclophosphamide and fludarabine
- Author
-
Shinichiro Okamoto, Hiroki Yokoyama, Masahiro Onoda, Taku Kikuchi, Chikako Ohwada, Yuhei Nagao, Makoto Onizuka, Kunihiko Morita, Emiko Sakaida, Katsuhiro Shono, Jun Kato, Yutaro Hino, Kana Matsumoto, Tatsuzo Mishina, Yuya Koda, Hiroaki Shimizu, Akira Yokota, Yusuke Takeda, and Takehiko Mori
- Subjects
medicine.medical_specialty ,Intravenous busulfan ,Hematology ,Cyclophosphamide ,business.industry ,medicine.medical_treatment ,Hematopoietic stem cell transplantation ,Gastroenterology ,Fludarabine ,03 medical and health sciences ,0302 clinical medicine ,Pharmacokinetics ,030220 oncology & carcinogenesis ,Internal medicine ,medicine ,business ,Prospective cohort study ,Busulfan ,030215 immunology ,medicine.drug - Abstract
Busulfan (Bu) has been used in combination with fludarabine (Flu; BuFlu) or cyclophosphamide (Cy; BuCy) as conditioning for allogeneic hematopoietic stem cell transplantation (HSCT). This multi-institutional prospective study compared pharmacokinetic (PK) parameters of Bu between BuFlu and BuCy. Plasma Bu concentrations were measured by high-performance liquid chromatography at the first dose of the first and fourth days of intravenous Bu administrations (total of 16 doses of 0.8 mg/kg). Thirty-seven patients were evaluable (BuFlu, N = 18; BuCy, N = 19). The median age was significantly higher in BuFlu. In BuFlu, the median area under the blood concentration–time curve of Bu on the fourth day was 1183 μmol min/L (range 808–1509), which was significantly higher than that on the first day [1095 μmol min/L (range 822–1453), P
- Published
- 2020
- Full Text
- View/download PDF
48. Successful second autologous stem-cell transplantation for patients with relapsed and refractory POEMS syndrome
- Author
-
Tomoya Muto, Nagisa Oshima-Hasegawa, Yusuke Takeda, Sonoko Misawa, Arata Ishii, Satoshi Kuwabara, Shokichi Tsukamoto, Naoya Mimura, Tatsuzo Mishina, Yutaro Hino, Yurie Nagai, Shio Mitsukawa, Emiko Sakaida, Asuka Shibamiya, Chikako Ohwada, Tohru Iseki, Kensuke Kayamori, and Chiaki Nakaseko
- Subjects
Transplantation ,medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Treatment outcome ,Hematology ,Hematopoietic stem cell transplantation ,medicine.disease ,Surgery ,Autologous stem-cell transplantation ,Refractory ,medicine ,business ,POEMS syndrome - Published
- 2020
- Full Text
- View/download PDF
49. Simple Tuning and Low-Computational-Cost Controller for Enhancing Energy Efficiency of Autonomous-Driving Electric Vehicles
- Author
-
Yoichi Hori, Yusuke Takeda, Koji Sato, Hiroshi Fujimoto, and Mitsuhiro Hattori
- Subjects
Imagination ,Chemical substance ,business.product_category ,SIMPLE (military communications protocol) ,Computer science ,Mechanical Engineering ,media_common.quotation_subject ,Energy Engineering and Power Technology ,Linear-quadratic regulator ,Industrial and Manufacturing Engineering ,Automotive engineering ,Control theory ,Automotive Engineering ,Electric vehicle ,Electrical and Electronic Engineering ,business ,Efficient energy use ,media_common - Published
- 2020
- Full Text
- View/download PDF
50. Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification
- Author
-
Ayako Arai, Shouichi Ohga, Shigeyoshi Fujiwara, Tohru Kobayashi, Ichiro Yonese, Hiroshi Kimura, Asao Hirose, Shun Ichi Kimura, Masahide Yamamoto, Masanori Makita, Noriko Fukuhara, Tomoyuki Endo, Chizuko Sakashita, Osamu Miura, Yusuke Takeda, Masataka Ishimura, Ken-Ichi Imadome, Akihisa Sawada, and Yoshinori Ito
- Subjects
Adult ,Male ,Epstein-Barr Virus Infections ,Herpesvirus 4, Human ,Vincristine ,medicine.medical_specialty ,Adolescent ,Cyclophosphamide ,medicine.medical_treatment ,Hematopoietic stem cell transplantation ,CHOP ,World Health Organization ,Young Adult ,Chronic active EBV infection ,Japan ,Internal medicine ,medicine ,Humans ,Child ,Aged ,Chemotherapy ,Lymphoid Neoplasia ,business.industry ,Infant ,Hematology ,Middle Aged ,medicine.disease ,Chemotherapy regimen ,Child, Preschool ,Prednisolone ,Female ,business ,medicine.drug - Abstract
Systemic chronic active Epstein-Barr virus infection (sCAEBV) was defined as a T- or NK-cell neoplasm in the 2017 World Health Organization (WHO) classification. To clarify the clinical features of sCAEBV under this classification and review the effects of chemotherapy, we performed a nationwide survey in Japan from 2016 through 2018 of patients with sCAEBV newly diagnosed from January 2003 through March 2016. One hundred cases were evaluated. The patients were aged 1 to 78 years (median, 21) and included 53 males and 47 females. Spontaneous regression was not observed in patients with active disease. In the childhood-onset group (age, 45 years) were female. The prognosis of the childhood-onset group was better than those of the adolescent/adult- and elderly-onset groups. The main chemotherapies used were a combination of cyclosporine A, steroids, and etoposide (cooling therapy) in 52 cases and cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP) in 45 cases. The rate of complete response (CR), defined as complete resolution of disease activity, was 17% for cooling therapy and 13% for CHOP. Virological CR was not observed. The 3-year overall survival rates in patients treated with chemotherapy only (n = 20), chemotherapy followed by allogeneic hematopoietic stem cell transplantation (allo-HSCT; n = 47), and allo-HSCT only (n = 12) were 0%, 65%, and 82%, respectively. Distinct characteristics were observed between childhood- and elderly-onset sCAEBV, and they appeared to be different disorders. Chemotherapy is currently insufficient to resolve disease activity and eradicate infected cells. The development of an effective treatment is urgently needed.
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.